Kiyatec Receives Investment from Brain Cancer Venture Philanthropy Funds
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Stay updated with breaking news from Matt Gevaert. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
We continue to hear about new options to improve outcomes for cancer patients and one of those we learned about recently is coming from a South Carolina company utilizing 3D cell culture research from Clemson University. Mike Switzer interviews Dr. Matt Gevaert, CEO and founder of Kiyatek in Greenville, SC.
Founded in 2005, Kiyatec is a commercial stage cancer diagnostics company born from technology developed at Clemson University.
Cancer diagnostics company plans move to innovation district